Novavax
World Rank (Jan-05-2024)
11,359
Market Cap (Jan-05-2024)
0.613 Billion USD
World Rank (Jul-30-2023)
10,617
Market Cap (Jul-30-2023)
0.708 Billion USD
World Rank (Dec-25-2022)
9,445
Market Cap (Dec-25-2022)
0.821 Billion USD
World Rank (Jan-07-2022)
1,955
Market Cap (Jan-07-2022)
9.58 Billion USD
Annual Revenue in USD
1,598 Million USD
Annual Net Income in USD
-657 Million USD
Annual Results for Period Ending
Dec-2022 ending year
Company Profile
Novavax is a Late Stage Biotechnology company that promotes improved global health through the discovery, development and commercialization of innovative vaccines to prevent serious infectious diseases. The company annual revenue is 157.0 million USD and 375 employees as on 2020. The headquarters is in USA.